drugset
drugset / Trial / NCT06041438

A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

NCT06041438 ↗

Phase 1 Completed 14 enrolled Boehringer Ingelheim
NaSequentialOpen-labelTreatment

Summary

The main objective of this trial is to investigate the effect on the exposure of BI 1584862 in plasma when given as single dose together with multiple doses of itraconazole (Test, T) as compared to BI 1584862 when given alone as oral single dose (Reference, R).

Timeline

Start
2023-09-29
Primary completion
2023-11-10
Completion
2023-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1584862 Unknown — Oral
Subject Itraconazole Small molecule 200 mg Oral

Indications

No indication recorded.